Kozian; Detlef

Patent Applications and Registrations

Patent applications and USPTO patent grants for Kozian; Detlef.The latest application filed is for "pyridine derivatives and their use in the treatment of conditions associated with pathological thrombus formation".

Company Profile

0.20.25

Kozian; Detlef - Frankfurt am Main DE
Kozian; Detlef - Kelkheim DE
Kozian; Detlef - Kelkeim DE
KOZIAN; Detlef - Hattersheim DE
Kozian; Detlef - Munchen DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Pyrazole derivatives and their use as LPAR5 antagonists Grant 9,346,762 - Nazare , et al. May 24, 2	2016-05-24
Pyridine derivatives and their use in the treatment of conditions associated with pathological thrombus formation Grant 9,346,757 - Nazare , et al. May 24, 2	2016-05-24
Benzo[1,3]dioxine derivatives and their use as LPAR5 antagonists Grant 9,221,784 - Nazare , et al. December 29, 2	2015-12-29
Pyrazole Derivatives And Their Use As LPAR5 Antagonists App 20150141477 - Nazare; Marc ; et al.	2015-05-21
Pyridine Derivatives And Their Use In The Treatment Of Conditions Associated With Pathological Thrombus Formation App 20150141471 - Nazare; Marc ; et al.	2015-05-21
Benzo[1,3]Dioxine Derivatives And Their Use As LPAR5 Antagonists App 20150111889 - Nazare; Marc ; et al.	2015-04-23
Method for the identification of a risk for a thrombogenic disorder by determining the TAFI-Ile347 polymorphism Grant 8,420,321 - Kozian , et al. April 16, 2	2013-04-16
EGLN2 variants and use thereof in preventing or treating thromboembolic disorders and coronary heart diseases Grant 8,329,167 - Kozian , et al. December 11, 2	2012-12-11
Association Of Edg5 Polymorphism V286a With Type Ii Diabetes Mellitus And Venous Thrombosis/pulmonary Embolism And The Use Thereof App 20120208200 - KOZIAN; Detlef ; et al.	2012-08-16
EGLN2 variants and use thereof in preventing or treating thromboembolic disorders and coronary heart diseases Grant 8,211,427 - Kozian , et al. July 3, 2	2012-07-03
Association of EDG5 polymorphism V286A with type II diabetes mellitus and venous thrombosis/pulmonary embolism and the use thereof Grant 8,198,022 - Kozian , et al. June 12, 2	2012-06-12
Egln2 Variants And Use Thereof In Preventing Or Treating Thromboembolic Disorders And Coronary Heart Diseases App 20120096571 - KOZIAN; Detlef ; et al.	2012-04-19
Method For The Diagnosis And Treatment Of Cardiovascular Diseases App 20120065078 - KOZIAN; Detlef ; et al.	2012-03-15
EGLN2 variants and use thereof in preventing or treating thromboembolic disorders and coronary heart disease Grant 8,114,398 - Kozian , et al. February 14, 2	2012-02-14
Use of a GIP promoter polymorphism Grant 8,084,198 - Kozian , et al. December 27, 2	2011-12-27
Method for the diagnosis and treatment of cardiovascular diseases Grant 8,071,297 - Kozian , et al. December 6, 2	2011-12-06
METHOD FOR THE IDENTIFICATION OF A RISK FOR A THROMBOGENIC DISORDER BY DETERMINING THE TAFl-lle347 POLYMORPHISM App 20110223628 - KOZIAN; Detlef ; et al.	2011-09-15
Method for the identification of a risk for a thrombogenic disorder by determining the TAFI-lle347 polymorphism Grant 7,985,562 - Kozian , et al. July 26, 2	2011-07-26
Egln2 Variants And Use Thereof In Preventing Or Treating Thromboembolic Disorders And Coronary Heart Diseases App 20110123515 - KOZIAN; Detlef ; et al.	2011-05-26
Association Of Edg5 Polymorphism V286a With Type Ii Diabetes Mellitus And Venous Thrombosis/pulmonary Embolism And The Use Thereof App 20110104704 - Kozian; Detlef ; et al.	2011-05-05
Analysis and use of PAR1 polymorphisms for evaluating the risk of cardiovascular disorders Grant 7,892,744 - Kozian , et al. February 22, 2	2011-02-22
Association of EDG5 polymorphism V286A with type II diabetes mellitus and venous thrombosis/pulmonary embolism and the use thereof Grant 7,888,020 - Kozian , et al. February 15, 2	2011-02-15
Use Of Clec1b For The Determination Of Cardiovascular And Thrombotic Risk App 20100311053 - Kozian; Detlef ; et al.	2010-12-09
Method Of Diagnosis Of A Predisposition To Develop Thrombotic Disease And Its Uses App 20100221738 - KOZIAN; Detlef ; et al.	2010-09-02
Analysis And Use Of Par1 Polymorphisms For Evaluating The Risk Of Cardiovascular Disease App 20100221714 - KOZIAN; Detlef ; et al.	2010-09-02
Method of diagnosis of a predisposition to develop thrombotic disease and its uses Grant 7,785,781 - Kozian , et al. August 31, 2	2010-08-31
Use Of Adamts4 Gene And Protein Polymorphisms App 20100062431 - Kozian; Detlef ; et al.	2010-03-11
Method For The Diagnosis And Treatment Of Cardiovascular Diseases App 20090239218 - Kozian; Detlef ; et al.	2009-09-24
METHOD FOR THE IDENTIFICATION OF A RISK FOR A THROMBOGENIC DISORDER BY DETERMINING THE TAFl-lle347 POLYMORPHISM App 20090239237 - KOZIAN; Detlef ; et al.	2009-09-24
Egln2 Variants And Use Thereof In Preventing Or Treating Thromboembolic Disorders And Coronary Heart Disease App 20090220479 - Kozian; Detlef ; et al.	2009-09-03
Method For Diagnosing Thromboembolic Disorders And Coronary Heart Disease App 20090197774 - Kozian; Detlef ; et al.	2009-08-06
Method for the identification of a risk for a thrombogenic disorder by determining the TAFI-Ile347 polymorphism Grant 7,560,290 - Kozian , et al. July 14, 2	2009-07-14
Use of a Gip Promoter Polymorphism App 20080312098 - Kozian; Detlef ; et al.	2008-12-18
Method of Diagnosis of a Predisposition to Develop Thrombotic Disease and Its Uses App 20080038722 - Kozian; Detlef ; et al.	2008-02-14
Association Of Edg5 Polymorphism V286a With Type Ii Diabetes Mellitus And Venous Thrombosis/pulmonary Embolism And The Use Thereof App 20070298509 - KOZIAN; Detlef ; et al.	2007-12-27
Association of Protein Polymorphisms With Coronary Heart Disease App 20070292859 - Kozian; Detlef ; et al.	2007-12-20
Association of EDG5 polymorphism V286A with type II diabetes mellitus and venous thrombosis/pulmonary embolism and the use thereof Grant 7,262,273 - Kozian , et al. August 28, 2	2007-08-28
Method for the identification of a risk for a thrombogenic disorder by determining the TAFI-IIe347 polymorphism App 20060040296 - Kozian; Detlef ; et al.	2006-02-23
Analysis and use of PAR1 polymorphisms for evaluating the risk of cardiovascular disorders App 20050019795 - Kozian, Detlef ; et al.	2005-01-27
Two-color differential display as a method for detecting regulated genes Grant 6,645,741 - Kozian , et al. November 11, 2	2003-11-11
Promotor for functional characterization of G-protein coupled receptors in the yeast saccharomyces cerevisiae Grant 6,602,699 - Kozian , et al. August 5, 2	2003-08-05
Promotor for functional characterization of G-protein coupled receptors in the yeast saccharomyces cerevisiae App 20030059779 - Kozian, Detlef ; et al.	2003-03-27
Two-color differential display as a method for detecting regulated genes App 20020090636 - Kozian, Detlef ; et al.	2002-07-11
Two-color differential display as a method for detecting regulated genes Grant 6,342,376 - Kozian , et al. January 29, 2	2002-01-29

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.